The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic.
Sexton, K; Lennon, D; Oster, P; Crengle, S; Martin, D; Mulholland, K
; Percival, T; Reid, S; Stewart, J; O'Hallahan, J and
(2004)
The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic.
The New Zealand medical journal, 117 (1200).
U1015-.
ISSN 0028-8446
https://researchonline.lshtm.ac.uk/id/eprint/13084
The New Zealand Meningococcal Vaccine Strategy aims to end the devastating 14-year epidemic of B:4:P1.7b,4 group B meningococcal disease in New Zealand through a mass immunisation programme to all under 20 year olds using a tailor-made vaccine (MeNZB). This paper describes the scientific rationale, development, and key components of the New Zealand Meningococcal Vaccine Strategy. A summary of the efficacy and safety data of existing outer membrane vesicle group B meningococcal vaccines is included as these data critically support the Strategy.
Item Type | Article |
---|---|
Date Deposited | 17 Oct 2011 19:46 |
ORCID: https://orcid.org/0000-0001-7947-680X